Aspen Aerogels, Inc. (NYSE:ASPN) Short Interest Update

Aspen Aerogels, Inc. (NYSE:ASPNGet Free Report) saw a significant growth in short interest in the month of December. As of December 31st, there was short interest totalling 9,820,000 shares, a growth of 9.4% from the December 15th total of 8,980,000 shares. Based on an average daily trading volume, of 2,470,000 shares, the days-to-cover ratio is presently 4.0 days.

Institutional Trading of Aspen Aerogels

Large investors have recently modified their holdings of the stock. Rhumbline Advisers boosted its position in shares of Aspen Aerogels by 13.7% during the 2nd quarter. Rhumbline Advisers now owns 93,226 shares of the construction company’s stock worth $2,223,000 after acquiring an additional 11,205 shares in the last quarter. Victory Capital Management Inc. acquired a new stake in shares of Aspen Aerogels in the 2nd quarter valued at $230,000. American Century Companies Inc. increased its stake in shares of Aspen Aerogels by 562.3% in the 2nd quarter. American Century Companies Inc. now owns 770,729 shares of the construction company’s stock valued at $18,382,000 after purchasing an additional 654,350 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of Aspen Aerogels by 21.3% during the 2nd quarter. Dimensional Fund Advisors LP now owns 1,374,631 shares of the construction company’s stock worth $32,790,000 after buying an additional 240,921 shares in the last quarter. Finally, Renaissance Technologies LLC bought a new stake in shares of Aspen Aerogels during the 2nd quarter worth $8,340,000. 97.64% of the stock is owned by institutional investors and hedge funds.

Aspen Aerogels Stock Performance

NYSE:ASPN traded up $0.17 during mid-day trading on Friday, reaching $12.73. 1,371,812 shares of the company’s stock were exchanged, compared to its average volume of 1,388,320. Aspen Aerogels has a one year low of $10.75 and a one year high of $33.15. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.48 and a current ratio of 2.93. The business’s fifty day simple moving average is $13.47 and its two-hundred day simple moving average is $20.24. The firm has a market capitalization of $1.04 billion, a PE ratio of 1,273.77 and a beta of 2.14.

Analyst Ratings Changes

ASPN has been the topic of a number of recent research reports. Canaccord Genuity Group dropped their target price on Aspen Aerogels from $28.00 to $20.00 and set a “buy” rating on the stock in a research report on Thursday. StockNews.com upgraded shares of Aspen Aerogels to a “sell” rating in a report on Wednesday, November 13th. Barclays reduced their target price on shares of Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating for the company in a report on Tuesday, November 12th. HC Wainwright reiterated a “buy” rating and issued a $30.00 price target on shares of Aspen Aerogels in a research note on Wednesday, October 16th. Finally, Roth Mkm reduced their price objective on shares of Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating for the company in a research note on Friday, November 8th. One research analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, Aspen Aerogels presently has an average rating of “Moderate Buy” and an average target price of $29.11.

Check Out Our Latest Stock Analysis on Aspen Aerogels

Aspen Aerogels Company Profile

(Get Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Featured Articles

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.